Alexion Pharmaceuticals, Inc.

Value Access and Pricing Manager

Alexion Pharmaceuticals, Inc.  •  Italian Republic (Onsite)  •  3 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Do you want to shape how rare disease medicines reach patients across Italy? Are you ready to design pricing and access strategies that secure timely reimbursement while sustaining innovation and impact?

As Value Access and Pricing Manager, you will drive the country value, access, and pricing agenda for rare disease therapies. Working closely with Franchises and global partners, you will craft strategies that translate evidence into compelling value narratives, secure national and regional access, and position our medicines for sustainable adoption. Your work will directly influence how and when patients, clinicians, and healthcare systems benefit from breakthrough treatments. In this role, you will connect global guidance to local realities, anticipate regulatory shifts, and lead negotiations and submissions that matter.

You will be a catalyst for collaboration across Regulatory, Medical Affairs, Government Affairs, Commercial, and regional teams—ensuring decisions are grounded in data, aligned to brand goals, and ready for the evolving EU HTA and JCA landscape.

Accountabilities:

  • Country Value & Access Leadership: Act as the key partner for Franchises on strategic Value & Access initiatives—from launch planning to evidence generation and brand planning—ensuring alignment and timely escalation to the Market Access Director.
  • Global Alignment: Serve as the local counterpart for Global Value Access & Pricing (GVAP) and Global HEOR, aligning the local value message to global strategy and elevating local needs to the global level.
  • Pricing Strategy for Italy: Contribute to the definition of P&R strategy for pipeline products and new indications, developing pricing scenarios in line with global guidelines to secure sustainable access.
  • National Reimbursement Dossiers: Lead the preparation and finalization of national reimbursement dossiers and P&R submissions to AIFA; contribute to negotiations with analyses, evidence, and negotiation positions that strengthen outcomes.
  • Managed Entry Agreements: Design and evaluate outcome-based and risk-sharing models, registries, and monitoring requirements that enable responsible, sustainable access.
  • Innovativeness Status and Dedicated Funds: Manage innovativeness status requests and related access to dedicated funds in collaboration with cross-functional teams.
  • P&R Lifecycle Management: Manage indication extensions, price reviews, and renegotiations with AIFA, ensuring continuity of access and optimal positioning.
  • Policy and HTA Monitoring: Monitor national P&R regulations (e.g., spending ceilings, payback) and the implementation of the EU HTA Regulation and JCA; assess portfolio and pipeline impact and coordinate with GVAP and Global HEOR to ensure evidence readiness.
  • Health Economic Modeling and Communications: Conduct local adaptation of budget impact and cost-effectiveness models; prepare clear communication materials on value, access, and price for stakeholders involved in the access and reimbursement process.
  • Access Tracking: Closely monitor national, regional, and local access status across the rare disease portfolio and pipeline products to drive timely interventions.
  • Regional Support: Support Regional Value & Access Managers in the preparation of regional reimbursement dossiers; share national strategy and key value materials; collect field input and customer insights for evidence generation plans.
  • Cross-Functional Compliance and Launch Readiness: Work with Regulatory, Compliance, Legal, Marketing, and Medical Affairs to ensure compliance and to contribute to launch strategies through reimbursement tools.
  • Program and Stakeholder Management: Prioritize and manage multiple projects, coordinate external consultants, and represent the Italian perspective on P&R policies and strategies in internal international forums.

Essential Skills/Experience:

  • Degree in Life Sciences (e.g., Pharmacy, Biology, Biotechnology) or Health Economics
  • At least 5 years of relevant work experience in market access and pricing within the pharmaceutical/biotech/medical device industry and/or health economics consulting firms
  • Solid knowledge of pharmacoeconomic analysis, pricing, and HTA, including the EU HTA Regulation and JCA
  • Knowledge of the Italian healthcare system, AIFA, and regional P&R processes
  • Fluent Italian and English, both written and spoken
  • Ability to anticipate healthcare policy, market access, and pharmacoeconomic issues in Italy that may impact reimbursement, with an open mind about new P&R approaches in rare and ultra-rare diseases
  • Strong negotiation, communication, project management, and analytical skills, with the ability to manage complex situations and work effectively in a cross-functional matrix
  • Based in, or willing to relocate to, Milan, as the position is office-based

Desirable Skills/Experience:

  • Experience in market access and pricing of orphan drugs and rare disease products
  • Postgraduate degree or certification in Health Economics, Pharmacoeconomics, or a related field (e.g., Master’s, MBA)
  • Curiosity about Artificial Intelligence and enthusiasm for exploring how Generative AI, automation, and digital technologies can enhance healthcare, market access, and ways of working

We carefully consider all applications, including those from candidates eligible under Italian Protected Categories legislation (Art. 1 and Art. 18, L. 68/99).

Why AstraZeneca:

Join a team where bold ideas and practical execution come together to move life-changing medicines to the people who need them most. You will work with the entrepreneurial energy of a leading biotech backed by the scale and investment of a global biopharma, in a culture that values kindness alongside ambition. We bring unexpected teams into the same room to challenge assumptions, connect deeply to patient lived experiences, and turn complex science and evidence into access that matters. In-person collaboration several days a week fuels pace and clarity, while flexibility respects individual needs.

Here, your expertise in access and pricing is amplified by supportive leaders, tailored development, and the chance to shape what comes next for rare disease care.

Call to Action: If you’re ready to lead pricing and access decisions that change the trajectory of rare disease care in Italy, step into this role and create impact that endures.

We offer:

Contract Level: A1 or A3, depending on the candidate’s experience in the role.

CBA: Chemical-Pharmaceutical

Full-time

Permanent

Date Posted

18-nov-2026

Closing Date

02-dic-2026

Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact accommodations@Alexion.com. Alexion participates in E-Verify.

Alexion Pharmaceuticals, Inc.

About Alexion Pharmaceuticals, Inc.

Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease.

A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities.

As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US.

Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally.

GL/NP/0116

GL/NP/0095

Community Guidelines: https://bit.ly/39x9gqy

Industry
Biotech & Life Sciences
Company Size
5,001-10,000 employees
Headquarters
Boston, Massachusetts
Year Founded
1992
Social Media